Position in TMO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$28,586,043
-$26,316,383 QoQ
Shares Held
57,017
-49.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
5.35%
of 13F equity value
Holder Rank
#390
of 2,606 holders
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Derivatives in TMO
reported options exposure · as of Mar 31, 2026CallValue
$24,576,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Arvin Capital Management LP holds $60,838,789 across 3 Diagnostics & Research names. TMO ranks #1 (47.0% of the industry book) .
All Filings in TMO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,586,043 | 57,017 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $24,576,500 | 50,000 | Call | Sole | 2026-05-14 | |
| 2026-03-31 | $54,902,426 | 111,697 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $39,286,710 | 67,800 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $39,999,599 | 82,470 | Shares | Sole | 2025-11-12 | |
| 2025-09-30 | $8,730,360 | 18,000 | Call | Sole | 2025-11-12 | |
| 2025-06-30 | $21,070,539 | 51,967 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $4,865,520 | 12,000 | Call | Sole | 2025-08-13 | |
| 2023-12-31 | $3,476,143 | 6,549 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||